Breaking News Instant updates and real-time market news.

2022-06-17 07:12:20 ITT ITT $65.66 / -2.691 (-3.94%) 07:12 06/17/22 06/17 07:12 06/17/22 07:12	ITT remains a top idea following analyst day, says Baird Baird analyst Michael Halloran said ITT hosted its first analyst day since 2011 in which management showcased growth drivers across segments, products, and/markets including updates on cyclical and secular trends, reiterated the commitment to M&A, highlighted its best-in-class execution, and provided a long-term financial framework. The analyst noted ITT's balance sheet is an underappreciated lever which is robust enough to manage organic investments, M&A, dividends, and share repurchases simultaneously. Halloran reiterated his Outperform rating and $84 price target on ITT shares.

2022-06-17 07:12:20

ITT

$65.66 / -2.691 (-3.94%)

07:12

06/17/22

06/17

07:12

06/17/22

07:12

ITT remains a top idea following analyst day, says Baird

Baird analyst Michael Halloran said ITT hosted its first analyst day since 2011 in which management showcased growth drivers across segments, products, and/markets including updates on cyclical and secular trends, reiterated the commitment to M&A, highlighted its best-in-class execution, and provided a long-term financial framework. The analyst noted ITT's balance sheet is an underappreciated lever which is robust enough to manage organic investments, M&A, dividends, and share repurchases simultaneously. Halloran reiterated his Outperform rating and $84 price target on ITT shares.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Beyond Meat Chief Brand Officer sold 25,573 shares » 09:56 08/11/22 08/11 09:56 08/11/22 09:56 BYND Beyond Meat $38.75 / +1.75 (+4.73%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BYND Beyond Meat $38.75 / +1.75 (+4.73%) 08/04/22 Beyond Meat sees reduction in warehouse costs following reduction in inventory 08/04/22 Beyond Meat sees delay in post-COVID resumption of growth 08/04/22 Beyond Meat announces 4% workforce reduction 07/28/22 Beyond Meat falls 4% after JPMorgan says McDonald's test done in U.S. BYND Beyond Meat $38.75 / +1.75 (+4.73%) 08/08/22 Mizuho Beyond Meat price target raised to $27 from $21 at Mizuho 08/08/22 Barclays Beyond Meat price target raised to $30 from $25 at Barclays 08/05/22 BMO Capital Beyond Meat price target lowered to $20 from $30 at BMO Capital 08/05/22 BofA Beyond Meat price target lowered to $10 from $20 at BofA BYND Beyond Meat $38.75 / +1.75 (+4.73%) 08/04/22 Beyond Meat cuts FY22 revenue view to $470M-$520M from $560M-$620M 08/04/22 Beyond Meat reports Q2 EPS ($1.53), consensus ($1.18) 08/04/22 Notable companies reporting after market close 05/11/22 Beyond Meat backs FY22 revenue view of $560M-$620M, consensus $588.87M BYND Beyond Meat $38.75 / +1.75 (+4.73%) 08/04/22 Beyond Meat eliminates about 40 positions amid cost cutting, Bloomberg reports 07/29/22 McDonald's tells CNBC it ended U.S. McPlant test 07/21/22 Beyond Meat struggling to deliver on Yum! partnership, Bloomberg says 06/29/22 Beyond Meat CEO says company to launch slice-steak product, WSJ reports BYND Beyond Meat $38.75 / +1.75 (+4.73%) 08/01/22 Short Report: Bets against Beyond Meat pared as McPlant test ends 07/28/22 What You Missed On Wall Street On Thursday 07/28/22 What You Missed On Wall Street This Morning 07/21/22 What You Missed On Wall Street On Thursday BYND Beyond Meat $38.75 / +1.75 (+4.73%) 08/04/22 Beyond Meat options imply 15.3% move in share price post-earnings 07/19/22 Largest borrow rate increases among liquid names 07/18/22 Beyond Meat call volume above normal and directionally bullish 07/18/22 Largest borrow rate increases among liquid names
Options	Early notable gainers among liquid option names on August 11th » 09:55 08/11/22 08/11 09:55 08/11/22 09:55 DIS Disney $122.80 / +10.24 (+9.10%) , WBD Warner Bros. Discovery $13.46 / +0.38 (+2.91%) , DVN Devon Energy $62.20 / +2.15 (+3.58%) , PARA Paramount $26.18 / +1.11 (+4.43%) , BKR Baker Hughes $25.37 / +1.01 (+4.15%) Notable gainers among… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DIS WBD DVN PARA BKR DIS Disney $122.80 / +10.24 (+9.10%) 08/10/22 Disney CFO says Q4 will see 'modest' subscriber growth acceleration 08/10/22 Disney CEO says working hard to announce something on sports betting 08/10/22 Disney sees FY24 core Disney+ subs at 135M-165M, Hotstar at up to 80M subs 08/10/22 Disney cuts FY22 capex by about $500M to $5.0B vs. $3.6B in FY21 WBD Warner Bros. Discovery $13.46 / +0.38 (+2.91%) 08/04/22 Warner Bros. Discovery backs long-term leverage target of 2.5-3.0 08/04/22 Warner Bros. Discovery sees FY23 adjusted EBITDA of 'at least $12B' 08/04/22 AT&T, Warner Bros. Discovery announces distribution pact for HBO Max 08/04/22 Warner Bros. Discovery launches dedicated CNN Originals hub on discovery+ DVN Devon Energy $62.20 / +2.15 (+3.58%) 08/09/22 Devon Energy to acquire Validus Energy for $1.8B 08/01/22 Devon Energy reports fixed-plus-variable dividend of $1.55, up 22% sequentially 08/01/22 Devon Energy trading resumes 08/01/22 Devon Energy raises FY22 guidance for production, free cash flow PARA Paramount $26.18 / +1.11 (+4.43%) 08/04/22 Paramount says seeing weakness in macro advertising market 08/04/22 Paramount says direct to consumer losses will be greatest in 2023 08/04/22 Paramount says 'clearly navigating some near term headwinds' 08/03/22 Paramount+ to launch as a Premium Subscription within Roku Channel BKR Baker Hughes $25.37 / +1.01 (+4.15%) 08/08/22 One Equity Partners agrees to sell power generation business of UK's BRUSH Group 08/08/22 Baker Hughes acquires Power Generation division of BRUSH group 08/05/22 Baker Hughes reports U.S. rig count down 3 to 764 rigs 08/05/22 Baker Hughes reports U.S. rig count down 3 to 764 rigs DIS WBD DVN PARA BKR DIS Disney $122.80 / +10.24 (+9.10%) 08:40 Today Credit Suisse Disney price target lowered to $157 from $170 at Credit Suisse 07:20 Today JPMorgan Disney price target lowered to $160 from $175 at JPMorgan 07:18 Today KeyBanc Disney price target raised to $154 from $131 at KeyBanc 06:49 Today Wells Fargo Disney price target raised to $145 from $130 at Wells Fargo WBD Warner Bros. Discovery $13.46 / +0.38 (+2.91%) 06:49 Today Wells Fargo Disney price target raised to $145 from $130 at Wells Fargo 08/10/22 Oppenheimer Trade Desk price target raised to $78 from $60 at Oppenheimer 08/08/22 Barrington Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington 08/05/22 Wells Fargo Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo DVN Devon Energy $62.20 / +2.15 (+3.58%) 08/10/22 Truist Devon Energy price target raised to $115 from $110 at Truist 07/22/22 Piper Sandler Devon Energy price target lowered to $94 from $97 at Piper Sandler 07/19/22 Truist Devon Energy price target raised to $115 from $103 at Truist 07/19/22 BofA Devon Energy price target lowered to $66 from $80 at BofA PARA Paramount $26.18 / +1.11 (+4.43%) 08/05/22 Deutsche Bank Paramount price target lowered to $32 from $35 at Deutsche Bank 08/05/22 JPMorgan JPMorgan downgrades Paramount to Underweight on soft DTC revenue 08/05/22 Morgan Stanley Paramount price target lowered to $20 from $22 at Morgan Stanley 08/05/22 JPMorgan Paramount downgraded to Underweight from Neutral at JPMorgan BKR Baker Hughes $25.37 / +1.01 (+4.15%) 07/21/22 RBC Capital Baker Hughes price target lowered to $36 from $41 at RBC Capital 07/21/22 Wells Fargo Baker Hughes price target lowered to $36 from $43 at Wells Fargo 07/21/22 Susquehanna Baker Hughes price target lowered to $35 from $39 at Susquehanna 07/21/22 BMO Capital Baker Hughes price target lowered to $30 from $33 at BMO Capital DIS WBD DVN PARA BKR DIS Disney $122.80 / +10.24 (+9.10%) 08/10/22 Disney reports Q3 EPS ex-items $1.09, consensus $1.00 08/10/22 Notable companies reporting after market close 05/11/22 Disney reports Q2 EPS ex-items $1.08, consensus $1.17 05/11/22 Notable companies reporting after market close WBD Warner Bros. Discovery $13.46 / +0.38 (+2.91%) 08/04/22 Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B 08/04/22 Warner Bros. Discovery reports Q2 EPS with items ($1.50), consensus (3c) 08/04/22 Notable companies reporting after market close 04/26/22 Warner Bros. Discovery reports Q1 diluted EPS 69c vs. 21c a year ago DVN Devon Energy $62.20 / +2.15 (+3.58%) 08/01/22 Devon Energy reports Q2 adjusted EPS $2.59, consensus $2.38 05/02/22 Devon Energy reports Q1 EPS $1.88, consensus $1.75 02/15/22 Devon Energy reports Q4 adjusted EPS $1.39, consensus $1.24 PARA Paramount $26.18 / +1.11 (+4.43%) 08/04/22 Paramount reports Q2 EPS 53c, consensus 62c 08/03/22 Notable companies reporting before tomorrow's open 08/03/22 Notable companies reporting before tomorrow's open 05/03/22 Paramount reports Q1 EPS 60c, consensus 51c BKR Baker Hughes $25.37 / +1.01 (+4.15%) 07/20/22 Baker Hughes reports Q2 EPS 11c, consensus 22c 04/20/22 Baker Hughes reports Q1 EPS 15c, consensus 19c 04/20/22 Baker Hughes reports Q1 adjusted EPS 15c, consensus 19c 04/19/22 Notable companies reporting before tomorrow's open DIS WBD PARA BKR DIS Disney $122.80 / +10.24 (+9.10%) 08/09/22 CBS near deal for Big Ten rights as ESPN walks away, Bloomberg reports 08/09/22 Walmart weighs streaming deal with Paramount, Disney, Comcast, NYT reports 08/02/22 Netflix, Disney, Hulu sued by Texas cities for unpaid fees, NY Post reports 07/25/22 EA making Black Panther video game, VentureBeat says WBD Warner Bros. Discovery $13.46 / +0.38 (+2.91%) 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says 08/05/22 Warner Bros. Discovery exploring free, ad-supported streaming, WSJ reports 08/04/22 Warner Bros. Discovery to combine HBO Max, Discovery+ next summer, Verge says 08/04/22 Warner Bros. Discovery to restructure HBO Max, Discovery+, TheWrap reports PARA Paramount $26.18 / +1.11 (+4.43%) 08/09/22 CBS near deal for Big Ten rights as ESPN walks away, Bloomberg reports 08/09/22 Walmart weighs streaming deal with Paramount, Disney, Comcast, NYT reports 08/08/22 'Top Gun: Maverick' achieves seventh-highest domestic gross ever, CNBC says 07/11/22 U.S. box office sales rising closer to pre-pandemic levels, CNBC reports BKR Baker Hughes $25.37 / +1.01 (+4.15%) 04/21/22 Some U.S. oilfield firms join push for Venezuela resumption, Reuters says DIS WBD DVN PARA BKR DIS Disney $122.80 / +10.24 (+9.10%) 08:51 Today Fly Intel: Pre-market Movers 08/10/22 Fly Intel: After-Hours Movers 08/10/22 What Wall Street is saying about Disney ahead of earnings 08/09/22 What You Missed On Wall Street On Tuesday WBD Warner Bros. Discovery $13.46 / +0.38 (+2.91%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/07/22 Box Office Battle: ‘Bullet Train’ wins weekend with $30.1M debut DVN Devon Energy $62.20 / +2.15 (+3.58%) 06/21/22 Fly Insider: ABM, Box among week's notable inside trades 06/07/22 What You Missed On Wall Street On Tuesday 06/07/22 What You Missed On Wall Street This Morning 06/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PARA Paramount $26.18 / +1.11 (+4.43%) 08/10/22 What Wall Street is saying about Disney ahead of earnings 08/09/22 What You Missed On Wall Street On Tuesday 08/07/22 Box Office Battle: ‘Bullet Train’ wins weekend with $30.1M debut 08/05/22 What You Missed On Wall Street On Friday BKR Baker Hughes $25.37 / +1.01 (+4.15%) 07/20/22 What You Missed On Wall Street On Wednesday 07/20/22 What You Missed On Wall Street This Morning 07/20/22 Fly Intel: Pre-market Movers 07/05/22 What You Missed On Wall Street This Morning 09/08/22 Consumer/Media/Entertainment Conference DIS WBD DVN PARA BKR DIS Disney $122.80 / +10.24 (+9.10%) 08:55 Today Notable open interest changes for August 11th 08/10/22 Disney options imply 5.4% move in share price post-earnings 07/20/22 Early notable gainers among liquid option names on July 20th 07/20/22 Unusually active option classes on open July 20th WBD Warner Bros. Discovery $13.46 / +0.38 (+2.91%) 08/09/22 Warner Bros Discovery Inc put volume heavy and directionally bearish 08/05/22 Notable open interest changes for August 5th 08/04/22 Notable open interest changes for August 4th 08/03/22 Warner Bros Discovery Inc call volume above normal and directionally bullish DVN Devon Energy $62.20 / +2.15 (+3.58%) 08/09/22 Early notable gainers among liquid option names on August 9th 08/01/22 Devon Energy options imply 6.0% move in share price post-earnings 07/13/22 Early notable gainers among liquid option names on July 13th 06/27/22 Early notable gainers among liquid option names on June 27th PARA Paramount $26.18 / +1.11 (+4.43%) 08/08/22 Early notable gainers among liquid option names on August 8th 05/18/22 Paramount Global call volume above normal and directionally bullish 05/17/22 Early notable gainers among liquid option names on May 17th 05/17/22 Unusually active option classes on open May 17th BKR Baker Hughes $25.37 / +1.01 (+4.15%) 03/21/22 Baker Hughes put volume heavy and directionally bearish 03/07/22 Early notable gainers among liquid option names on March 7th 02/11/22 Early notable gainers among liquid option names on February 11th
Recommendations	New York Times share buys at UBS flagged by Gordon Haskett on activist link » 09:52 08/11/22 08/11 09:52 08/11/22 09:52 NYT New York Times $32.10 / +0.41 (+1.29%) , Z Zillow $39.61 / +0.34 (+0.87%) , ZG Zillow Group $39.75 / +0.445 (+1.13%) Gordon Haskett's… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 08/03/22 New York Times sees FY22 CapEx approximately $55M 07/14/22 Hasbro, New York Times to launch new Wordle board game 06/13/22 New York Times announces midterm targets at investor day 05/04/22 New York Times sees FY22 capital expenditures $53M Z Zillow $39.61 / +0.34 (+0.87%) 08/04/22 Zillow, Opendoor announce multi-year partnership 05/05/22 Zillow drops 9% to $36.21 after Q2 revenue guidance misses estimates 05/05/22 Zillow Group falls over 9% to $35.27 after Q1 results, below-consensus guidance 05/05/22 Zillow Group board approves $1.0B buyback ZG Zillow Group $39.75 / +0.445 (+1.13%) 08/04/22 Zillow, Opendoor announce multi-year partnership 05/05/22 Zillow drops 9% to $36.21 after Q2 revenue guidance misses estimates 05/05/22 Zillow Group falls over 9% to $35.27 after Q1 results, below-consensus guidance 05/05/22 Zillow Group board approves $1.0B buyback NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 08/04/22 Morgan Stanley New York Times price target lowered to $37 from $40 at Morgan Stanley 07/21/22 Guggenheim New York Times price target lowered to $34 from $41 at Guggenheim 06/22/22 Cannonball Research 'Not right market for' NYT story, Cannonball Research says in downgrade 06/22/22 Cannonball Research New York Times downgraded to Neutral from Buy at Cannonball Research Z Zillow $39.61 / +0.34 (+0.87%) 08/08/22 Stifel Zillow Group price target lowered to $37 from $40 at Stifel 08/05/22 Wedbush Zillow Group downgraded to Neutral on mortgage drag at Wedbush 08/05/22 Wedbush Zillow Group downgraded to Neutral from Outperform at Wedbush 08/05/22 Piper Sandler Zillow Group price target lowered to $31 from $39 at Piper Sandler ZG Zillow Group $39.75 / +0.445 (+1.13%) 08/08/22 Truist Zillow Group price target lowered to $37 from $41 at Truist 08/08/22 Stifel Zillow Group price target lowered to $37 from $40 at Stifel 08/05/22 RBC Capital Zillow Group price target lowered to $42 from $46 at RBC Capital 08/05/22 Canaccord Zillow Group price target lowered to $55 from $60 at Canaccord NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 08/03/22 New York Times reports Q2 adjusted EPS 24c, consensus 19c 05/04/22 New York Times reports Q1 adjusted EPS 19c, consensus 18c Z Zillow $39.61 / +0.34 (+0.87%) 08/04/22 Zillow Group sees Q3 adjusted EBITDA $73M-$78M 08/04/22 Zillow Group reports Q2 adjusted EBITDA $164M vs $183M last year 08/04/22 Notable companies reporting after market close 05/05/22 Zillow Group sees Q2 revenue $903M-$1.03B, consensus $1.81B ZG Zillow Group $39.75 / +0.445 (+1.13%) 08/04/22 Zillow Group sees Q3 adjusted EBITDA $73M-$78M 08/04/22 Zillow Group reports Q2 adjusted EBITDA $164M vs $183M last year 08/04/22 Notable companies reporting after market close 05/05/22 Zillow Group sees Q2 revenue $903M-$1.03B, consensus $1.81B NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 06/10/22 Facebook reviewing news deals, no indications of renewing, WSJ reports 06/08/22 Kara Swisher leaving New York Times for Vox Media, Bloomberg reports 04/07/22 NY Times' Baquet, in 'major shift,' makes Twitter presence 'optional,' WaPo says 03/08/22 New York Times removes news staff from Russia, NYT reports Z Zillow $39.61 / +0.34 (+0.87%) 07/30/22 Opendoor stock could double, Barron's says 04/14/22 Mortgage rates spike to 5% amid post-pandemic price pressures, NY Times says ZG Zillow Group $39.75 / +0.445 (+1.13%) 07/30/22 Opendoor stock could double, Barron's says NYT Z ZG NYT New York Times $32.10 / +0.41 (+1.29%) 06/13/22 What You Missed On Wall Street On Monday 06/13/22 What You Missed On Wall Street This Morning 03/08/22 What You Missed On Wall Street This Morning 03/04/22 What You Missed On Wall Street This Morning Z Zillow $39.61 / +0.34 (+0.87%) 08/05/22 What You Missed On Wall Street This Morning 08/04/22 Fly Intel: After-Hours Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ZG Zillow Group $39.75 / +0.445 (+1.13%) 08/04/22 Fly Intel: After-Hours Movers 06/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning 09/08/22 Consumer/Media/Entertainment Conference 08/23/22 Zillow Group Z Z Zillow $39.61 / +0.34 (+0.87%) 08/04/22 Zillow options imply 11.0% move in share price post-earnings 07/22/22 Zillow put volume heavy and directionally bearish 07/05/22 Zillow call volume above normal and directionally bullish 06/17/22 Unusually active option classes on open June 17th
Hot Stocks	Zhong Yang Financial Group Ltd trading resumes 09:50 08/11/22 08/11 09:50 08/11/22 09:50 TOP Top Financial $13.30 / +0.87 (+7.00%) ShowHide Related Items >><< Company News Syndicate On The Fly TOP Top Financial $13.30 / +0.87 (+7.00%) 09:37 Today Zhong Yang Financial Group Ltd trading halted, volatility trading pause 08/09/22 Zhong Yang Financial Group Ltd trading resumes 08/09/22 Zhong Yang Financial Group Ltd trading halted, volatility trading pause 08/08/22 Zhong Yang Financial Group Ltd trading resumes 01 Jun TOP Top Financial $13.30 / +0.87 (+7.00%) 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO 06/04/22 Opening Day: Zhong Yang rises 240% in market debut
Hot Stocks	Alpha Teknova Inc trading resumes 09:49 08/11/22 08/11 09:49 08/11/22 09:49 TKNO Alpha Teknova $5.60 / -0.2 (-3.45%) ShowHide Related Items >><< Company News Street Research Earnings Events TKNO Alpha Teknova $5.60 / -0.2 (-3.45%) 09:44 Today Alpha Teknova Inc trading halted, volatility trading pause TKNO Alpha Teknova $5.60 / -0.2 (-3.45%) 06:34 Today Stephens Alpha Teknova price target lowered to $15 from $22 at Stephens 10/14/21 Cowen Alpha Teknova price target raised to $30 from $24 at Cowen TKNO Alpha Teknova $5.60 / -0.2 (-3.45%) 08/10/22 Alpha Teknova reports Q2 EPS (22c) vs. (52c) in last year's quarter 03/15/22 Alpha Teknova sees FY22 revenue $44M-$48M, consensus $42.04M 03/15/22 Alpha Teknova reports Q4 EPS (13c), consensus (17c) 02/28/22 Alpha Teknova sees Q4 revenue $10-$10.1M, consensus $8.45M 08/29/22 Med Tech & Life Sciences West Coast Field Trip
Recommendations	Haemonetics price target raised to $90 from $80 at JMP Securities » 09:48 08/11/22 08/11 09:48 08/11/22 09:48 HAE Haemonetics $74.08 / +0.5 (+0.68%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HAE Haemonetics $74.08 / +0.5 (+0.68%) 09:47 Today Haemonetics shares rose 9% on Wednesday following Q1 results 07/11/22 Axogen appoints William Burke to board of directors 06/24/22 Haemonetics completes move to manufacturing facility in Clinton, PA 05/10/22 Haemonetics rises 16.0% HAE Haemonetics $74.08 / +0.5 (+0.68%) 09:05 Today Barrington Haemonetics price target raised to $88 from $77 at Barrington 07/01/22 Morgan Stanley Haemonetics price target raised to $70 from $60 at Morgan Stanley 05/11/22 Barrington Haemonetics price target raised to $77 from $71 at Barrington 02/09/22 Barrington Haemonetics price target raised to $71 from $67 at Barrington HAE Haemonetics $74.08 / +0.5 (+0.68%) 05/10/22 Haemonetics sees 2023 adjusted EPS $2.50-$2.90, consensus $2.75 05/10/22 Haemonetics reports Q4 adjusted EPS 65c, consensus 60c
Hot Stocks	GSK plc falls -7.9% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 GSK GSK plc $35.26 / -3.055 (-7.97%) GSK plc is down -7.9%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GSK plc $35.26 / -3.055 (-7.97%) 08/08/22 Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056 08/08/22 GSK, IQVIA launch Vaccine Track platform 07/29/22 ViiV Healthcare presents five-year data at AIDS 2022 on fostemsavir 07/28/22 ViiV Healthcare announces data from unblinded phase of HPTN 084 study GSK GSK plc $35.26 / -3.055 (-7.97%) 08:34 Today Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank 08/09/22 Baird Mersana Therapeutics price target raised to $20 from $18 at Baird 08/08/22 UBS GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS 08/05/22 Morgan Stanley GSK plc resumed with an Equal Weight at Morgan Stanley GSK GSK plc $35.26 / -3.055 (-7.97%) 07/27/22 GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year 04/27/22 GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER 04/27/22 GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year 04/13/22 GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B GSK GSK plc $35.26 / -3.055 (-7.97%) 07:56 Today GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says GSK GSK plc $35.26 / -3.055 (-7.97%) 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed On Wall Street This Morning 08/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 What You Missed On Wall Street This Morning 09/10/22 ESMO Congress 2022 GSK GSK plc $35.26 / -3.055 (-7.97%) 08/10/22 GSK plc (ADR) call volume above normal and directionally bullish 07/29/22 GSK plc (ADR) call volume above normal and directionally bullish 07/22/22 Two new option listings and one option delisting on July 22nd 07/20/22 One new option listing and two option delistings on July 20th
Hot Stocks	Six Flags falls -18.1% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 SIX Six Flags $21.11 / -4.695 (-18.19%) Six Flags is down -18.1%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SIX Six Flags $21.11 / -4.695 (-18.19%) 08:04 Today Six Flags reports Q2 attendance 6.7M vs. 8.5M a year ago, down 22% 06:08 Today Six Flags drops 8% to $23.70 after Q2 results miss estimates 07/26/22 Novanta to replace Six Flags in the S&P 400 at open on 7/26 07/26/22 Six Flags to replace Natus Medical in the S&P 600 at open on 7/26 SIX Six Flags $21.11 / -4.695 (-18.19%) 07/08/22 Citi Six Flags downgraded to Neutral from Buy at Citi 06/24/22 Stifel Six Flags price target lowered to $35 from $52 at Stifel 06/21/22 B. Riley Six Flags downgraded to Neutral from Buy at B. Riley 05/13/22 Truist Six Flags price target lowered to $32 from $46 at Truist SIX Six Flags $21.11 / -4.695 (-18.19%) 06:00 Today Six Flags reports Q2 EPS 53c, consensus $1.02 08/10/22 Notable companies reporting before tomorrow's open 08/10/22 Notable companies reporting before tomorrow's open 05/12/22 Six Flags reports Q1 EPS (76c), consensus ($1.04) SIX Six Flags $21.11 / -4.695 (-18.19%) 08:51 Today Fly Intel: Pre-market Movers 07/21/22 Fly Intel: After-Hours Movers 07/08/22 What You Missed On Wall Street On Friday 07/08/22 What You Missed On Wall Street This Morning 08:00 Today Six Flags - SIX
Hot Stocks	Invitae falls -25.4% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 NVTA Invitae $6.44 / -2.3 (-26.32%) Invitae is down -25.4%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NVTA Invitae $6.44 / -2.3 (-26.32%) 09:42 Today Invitae trading resumes 09:37 Today Invitae trading halted, volatility trading pause 08/10/22 Invitae rises 46.1% 08/08/22 Cathie Wood's ARK Investment bought 813K shares of Invitae today NVTA Invitae $6.44 / -2.3 (-26.32%) 08/10/22 JPMorgan Invitae cut to Underweight at JPMorgan with future growth yet to be proven 08/10/22 JPMorgan Invitae downgraded to Underweight from Neutral at JPMorgan 07/26/22 Cowen Invitae cut to Market Perform at Cowen on debt refinancing uncertainty 07/26/22 Cowen Invitae downgraded to Market Perform from Outperform at Cowen NVTA Invitae $6.44 / -2.3 (-26.32%) 08/09/22 Invitae backs FY22 revenue growth of low double digits, consensus $542.96M 08/09/22 Invitae reports Q2 adjusted EPS (68c), consensus (76c) 07/18/22 Invitae sees second half of FY22 revenue flat over first half of FY22 07/18/22 Invitae sees Q2 revenue $136M, consensus $142.74M NVTA Invitae $6.44 / -2.3 (-26.32%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 07/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 Fly Intel: After-Hours Movers 09/10/22 ESMO Congress 2022 NVTA Invitae $6.44 / -2.3 (-26.32%) 08:00 Today Invitae call buyer realizes 3500% same-day gains 05/03/22 Invitae options imply 14.1% move in share price post-earnings 02/24/22 Invitae options imply 14.1% move in share price post-earnings
Hot Stocks	Haemonetics shares rose 9% on Wednesday following Q1 results » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 HAE Haemonetics $74.08 / +0.5 (+0.68%) Shares of Haemonetics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HAE Haemonetics $74.08 / +0.5 (+0.68%) 07/11/22 Axogen appoints William Burke to board of directors 06/24/22 Haemonetics completes move to manufacturing facility in Clinton, PA 05/10/22 Haemonetics rises 16.0% 03/21/22 Haemonetics names James D'Arecca CFO HAE Haemonetics $74.08 / +0.5 (+0.68%) 09:05 Today Barrington Haemonetics price target raised to $88 from $77 at Barrington 07/01/22 Morgan Stanley Haemonetics price target raised to $70 from $60 at Morgan Stanley 05/11/22 Barrington Haemonetics price target raised to $77 from $71 at Barrington 02/09/22 Barrington Haemonetics price target raised to $71 from $67 at Barrington HAE Haemonetics $74.08 / +0.5 (+0.68%) 05/10/22 Haemonetics sees 2023 adjusted EPS $2.50-$2.90, consensus $2.75 05/10/22 Haemonetics reports Q4 adjusted EPS 65c, consensus 60c

Hot Stocks	Solo Brands rises 14.7% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 DTC Solo Brands $6.96 / +0.97 (+16.19%) Solo Brands is up 14.7%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options DTC Solo Brands $6.96 / +0.97 (+16.19%) 08/09/22 Solo Brands rises 14.2% 05/27/22 Solo Brands rises 19.5% 05/27/22 Solo Brands rises 13.2% 05/12/22 Solo Brands falls -15.0% DTC Solo Brands $6.96 / +0.97 (+16.19%) 08/02/22 Citi Solo Brands transferred with Buy rating at Citi 05/13/22 Citi Solo Brands price target lowered to $11 from $16 at Citi 03/30/22 Citi Solo Brands price target lowered to $16 from $20 at Citi 01/11/22 Citi Solo Brands upgraded to Buy from Neutral at Citi DTC Solo Brands $6.96 / +0.97 (+16.19%) 06:55 Today Solo Brands sees FY22 revenue growth in mid-20% range, consensus $548.76M 06:54 Today Solo Brands reports Q2 adjusted EPS 40c, consensus 28c 05/12/22 Solo Brands sees FY22 revenue $540M-$570M, consensus $556.7M 05/12/22 Solo Brands reports Q1 adjusted EPS 19c, consensus 8c 28 Oct DTC Solo Brands $6.96 / +0.97 (+16.19%) 05/21/22 Short Report: Bearish bets increase in meme names GameStop and Carvana 03/29/22 What You Missed On Wall Street On Tuesday 03/29/22 What You Missed On Wall Street This Morning 03/29/22 Fly Intel: Pre-market Movers 08:30 Today Solo Brands - DTC DTC Solo Brands $6.96 / +0.97 (+16.19%) 04/20/22 Five new option listings and one option delisting on April 20th
Hot Stocks	Dutch Bros rises 17.9% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 BROS Dutch Bros $52.33 / +8.27 (+18.77%) Dutch Bros is up 17.9%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BROS Dutch Bros $52.33 / +8.27 (+18.77%) 06/15/22 Dutch Bros CEO: Demand is not where we would like it to be 05/12/22 Dutch Bros falls -28.4% 05/12/22 Dutch Bros falls -40.1% 05/12/22 Dutch Bros falls -35.8% BROS Dutch Bros $52.33 / +8.27 (+18.77%) 06:31 Today Baird Dutch Bros price target raised to $46 from $30 at Baird 06:14 Today Piper Sandler Dutch Bros price target raised to $50 from $44 at Piper Sandler 07/11/22 Baird Dutch Bros downgraded to Neutral from Outperform at Baird 06/09/22 Barclays Dutch Bros price target raised to $34 from $25 at Barclays BROS Dutch Bros $52.33 / +8.27 (+18.77%) 08/10/22 Dutch Bros backs FY22 revenue view at least $715M, consensus $713.11M 08/10/22 Dutch Bros reports Q2 adjusted EPS 5c, consensus 7c 05/11/22 Dutch Bros sees FY22 revenue $700M-$715M, consensus $717.22M 05/11/22 Dutch Bros reports Q1 adjusted EPS (2c), consensus 1c 11 Mar 15 Sep BROS Dutch Bros $52.33 / +8.27 (+18.77%) 08/10/22 Fly Intel: After-Hours Movers 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/21/22 Short Report: Bearish bets increase in meme names GameStop and Carvana 05/12/22 What You Missed On Wall Street This Morning BROS Dutch Bros $52.33 / +8.27 (+18.77%) 08/10/22 Dutch Bros options imply 13.3% move in share price post-earnings 08/09/22 Dutch Bros put volume heavy and directionally bearish 07/29/22 Largest borrow rate increases among liquid names 07/11/22 Largest borrow rate increases among liquid names
Hot Stocks	Vizio rises 20.9% » 09:47 08/11/22 08/11 09:47 08/11/22 09:47 VZIO Vizio $12.62 / +2.23 (+21.46%) Vizio is up 20.9%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events VZIO Vizio $12.62 / +2.23 (+21.46%) 07/26/22 Vizio up 3% after Protocol report on Comcast acquisition talks 06/23/22 Vizio Smart TVs now integrated with Tik Tok TV 05/12/22 Vizio sees Q2 adjusted EBITDA $3M-$7M 04/26/22 Nielsen expands Smart TV data deal with Vizio VZIO Vizio $12.62 / +2.23 (+21.46%) 08/08/22 BofA Vizio price target lowered to $15 from $17 at BofA 07/22/22 JPMorgan Vizio price target lowered to $14 from $20 at JPMorgan 07/12/22 Guggenheim Vizio price target lowered to $12 from $14 at Guggenheim 05/13/22 Piper Sandler Vizio price target lowered to $15 from $21 at Piper Sandler VZIO Vizio $12.62 / +2.23 (+21.46%) 08/10/22 Vizio sees Q3 adjusted EBITDA $8M-$13M 08/10/22 Vizio reports Q2 EPS 1c vs (8c) last year 05/12/22 Vizio reports Q1 EPS (6c), consensus (5c) 03/03/22 Vizio sees Q1 adjusted EBITDA ($2M)-$2M VZIO Vizio $12.62 / +2.23 (+21.46%) 07/26/22 Comcast approached Vizio about potential acquisition, Protocol says VZIO Vizio $12.62 / +2.23 (+21.46%) 08/10/22 Fly Intel: After-Hours Movers 05/12/22 Fly Intel: After-Hours Movers 09/08/22 Consumer/Media/Entertainment Conference 08/17/22 Vizio 09/06/22 Vizio
Downgrade	Coupang downgraded to Hold from Buy at Deutsche Bank » 09:46 08/11/22 08/11 09:46 08/11/22 09:46 CPNG Coupang $20.61 / +0.89 (+4.51%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CPNG Coupang $20.61 / +0.89 (+4.51%) 07/15/22 Coupang rises 7.9% 07/01/22 Coupang rises 13.4% 07/01/22 Coupang rises 9.1% 05/12/22 Coupang rises 24.8% CPNG Coupang $20.61 / +0.89 (+4.51%) 06:39 Today Mizuho Coupang price target raised to $22 from $18 at Mizuho 08/10/22 Macquarie Macquarie started Coupang at Outperform with $26 target yesterday 08/09/22 Macquarie Coupang initiated with an Outperform at Macquarie 06/30/22 Credit Suisse Coupang upgraded to Outperform at Credit Suisse following underperformance CPNG Coupang $20.61 / +0.89 (+4.51%) 08/10/22 Coupang raises FY22 adjusted EBITDA view 08/10/22 Coupang reports Q2 EPS (4c), consensus (11c) 05/11/22 Coupang reports Q1 EPS (12c), consensus (17c) 03/02/22 Coupang sees 2022 adjusted EBITDA loss less than ($400M) 14 Sep CPNG Coupang $20.61 / +0.89 (+4.51%) 03/28/22 Softbank's Alibaba shares in spotlight amid stock turbulence, WSJ reports CPNG Coupang $20.61 / +0.89 (+4.51%) 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 07/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations CPNG Coupang $20.61 / +0.89 (+4.51%) 08/10/22 Coupang options imply 10.6% move in share price post-earnings 07/20/22 Unusually active option classes on open July 20th 07/01/22 Coupang call volume above normal and directionally bullish 06/17/22 Coupang call volume above normal and directionally bullish
Hot Stocks	Main Street trading resumes 09:46 08/11/22 08/11 09:46 08/11/22 09:46 MAIN Main Street $44.86 / -0.005 (-0.01%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate MAIN Main Street $44.86 / -0.005 (-0.01%) 09:26 Today Main Street trading halted, news pending 08/02/22 Main Street raises dividend 2.3% to 66c 07/12/22 Main Street invests $19.5M in three market portfolio companies 04/14/22 Main Street originated $226.6M in new commitments in Q1 MAIN Main Street $44.86 / -0.005 (-0.01%) 08/08/22 Raymond James Main Street downgraded to Market Perform from Outperform at Raymond James 03/07/22 Hovde Group Main Street initiated with a Market Perform at Hovde Group 11/11/21 Truist Main Street price target raised to $43 from $40 at Truist 11/08/21 Raymond James Main Street price target raised to $47 from $44 at Raymond James MAIN Main Street $44.86 / -0.005 (-0.01%) 08/04/22 Main Street reports Q2 adjusted NII 78c, consensus 70c 05/05/22 Main Street reports Q1 NII 77c, consensus 70c 02/24/22 Main Street reports Q4 distribugtable NII 73c, consensus 65c 11 Aug
Hot Stocks	Veru trading resumes 09:44 08/11/22 08/11 09:44 08/11/22 09:44 VERU Veru $11.77 / -0.01 (-0.08%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VERU Veru $11.77 / -0.01 (-0.08%) 09:39 Today Veru trading halted, volatility trading pause 08/09/22 Veru announces presentation of phase 3 study of Sabizabulin 07/27/22 Veru says EMA's ETF initiates review of sabizabulin for COVID-19 patients 07/25/22 Veru announces UK's MHRA supports expedited review of MAA for sabizabulin VERU Veru $11.77 / -0.01 (-0.08%) 08/03/22 Oppenheimer Oppenheimer says analysis provides context on Veru COVID Phase 3 mortality rates 07/06/22 Jefferies Veru data likely portend FDA authorization in 30 days, says Jefferies 05/18/22 Brookline Veru price target raised to $31 from $29 at Brookline 05/13/22 Jefferies Veru price target raised to $55 from $33 at Jefferies VERU Veru $11.77 / -0.01 (-0.08%) 06:45 Today Veru reports Q3 EPS (28c), consensus (18c) 05/12/22 Veru reports Q2 EPS (18c), consensus (15c) VERU Veru $11.77 / -0.01 (-0.08%) 07/08/22 Culper Research says short Veru, sees ' little to no hope of' sabizabulin EUA 05/02/22 Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter' 04/11/22 STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm VERU Veru $11.77 / -0.01 (-0.08%) 07/08/22 What You Missed On Wall Street On Friday 07/08/22 What You Missed On Wall Street This Morning 07/06/22 Fly Intel: After-Hours Movers 07/06/22 What You Missed On Wall Street On Wednesday 08:00 Today Veru - VERU VERU Veru $11.77 / -0.01 (-0.08%) 07/07/22 Veru call volume above normal and directionally bullish 06/27/22 Veru call volume above normal and directionally bullish 06/07/22 Veru call volume above normal and directionally bullish 06/07/22 Unusually active option classes on open June 7th
Hot Stocks	Alpha Teknova Inc trading halted, volatility trading pause 09:44 08/11/22 08/11 09:44 08/11/22 09:44 TKNO Alpha Teknova $5.80 / -0.005 (-0.09%) ShowHide Related Items >><< Street Research Earnings Events TKNO Alpha Teknova $5.80 / -0.005 (-0.09%) 06:34 Today Stephens Alpha Teknova price target lowered to $15 from $22 at Stephens 10/14/21 Cowen Alpha Teknova price target raised to $30 from $24 at Cowen TKNO Alpha Teknova $5.80 / -0.005 (-0.09%) 08/10/22 Alpha Teknova reports Q2 EPS (22c) vs. (52c) in last year's quarter 03/15/22 Alpha Teknova sees FY22 revenue $44M-$48M, consensus $42.04M 03/15/22 Alpha Teknova reports Q4 EPS (13c), consensus (17c) 02/28/22 Alpha Teknova sees Q4 revenue $10-$10.1M, consensus $8.45M 08/29/22 Med Tech & Life Sciences West Coast Field Trip
Recommendations	Plug Power price target raised to $36 from $20 at Citi » 09:43 08/11/22 08/11 09:43 08/11/22 09:43 PLUG Plug Power $28.77 / -0.01 (-0.03%) Citi analyst P.J. Juvekar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PLUG Plug Power $28.77 / -0.01 (-0.03%) 08/04/22 New Fortress Energy enters 120MW green hydrogen plant deal with Plug Power 08/04/22 Plug Power selected by New Fortress Energy for 120 MW green hydrogen plant 07/29/22 Microsoft posts blog detailing work with partner Plug Power 07/12/22 Plug Power secures 5MW electrolyzer sale to Irving Oil PLUG Plug Power $28.77 / -0.01 (-0.03%) 09:25 Today Truist Plug Power price target raised to $32 from $21 at Truist 08/10/22 B. Riley Plug Power price target raised to $32 from $31 at B. Riley 08/10/22 Cowen Plug Power price target lowered to $35 from $44 at Cowen 08/10/22 BMO Capital Plug Power price target raised to $29 from $20 at BMO Capital PLUG Plug Power $28.77 / -0.01 (-0.03%) 08/09/22 Plug Power reports Q2 EPS (30c) vs. (18c) last year 08/09/22 Notable companies reporting after market close 05/09/22 Plug Power reports Q1 EPS (27c), consensus (16c) 05/09/22 Notable companies reporting after market close PLUG Plug Power $28.77 / -0.01 (-0.03%) 08/09/22 Fly Intel: After-Hours Movers 08/08/22 What You Missed This Week in EVs and Clean Energy 06/13/22 What You Missed This Week in EVs and Clean Energy 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/12/22 Annual Industrials, Energy & Airlines Conference PLUG Plug Power $28.77 / -0.01 (-0.03%) 07/28/22 Unusually active option classes on open July 28th 07/06/22 Plug Power call volume above normal and directionally bullish 06/27/22 Plug Power put volume heavy and directionally bearish 05/09/22 Unusually active option classes on open May 9th
Hot Stocks	Invitae trading resumes 09:42 08/11/22 08/11 09:42 08/11/22 09:42 NVTA Invitae $8.67 / -0.07 (-0.80%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NVTA Invitae $8.67 / -0.07 (-0.80%) 09:37 Today Invitae trading halted, volatility trading pause 08/10/22 Invitae rises 46.1% 08/08/22 Cathie Wood's ARK Investment bought 813K shares of Invitae today 07/18/22 Invitae announces strategic business realignment NVTA Invitae $8.67 / -0.07 (-0.80%) 08/10/22 JPMorgan Invitae cut to Underweight at JPMorgan with future growth yet to be proven 08/10/22 JPMorgan Invitae downgraded to Underweight from Neutral at JPMorgan 07/26/22 Cowen Invitae cut to Market Perform at Cowen on debt refinancing uncertainty 07/26/22 Cowen Invitae downgraded to Market Perform from Outperform at Cowen NVTA Invitae $8.67 / -0.07 (-0.80%) 08/09/22 Invitae backs FY22 revenue growth of low double digits, consensus $542.96M 08/09/22 Invitae reports Q2 adjusted EPS (68c), consensus (76c) 07/18/22 Invitae sees second half of FY22 revenue flat over first half of FY22 07/18/22 Invitae sees Q2 revenue $136M, consensus $142.74M NVTA Invitae $8.67 / -0.07 (-0.80%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 07/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 Fly Intel: After-Hours Movers 09/10/22 ESMO Congress 2022 NVTA Invitae $8.67 / -0.07 (-0.80%) 08:00 Today Invitae call buyer realizes 3500% same-day gains 05/03/22 Invitae options imply 14.1% move in share price post-earnings 02/24/22 Invitae options imply 14.1% move in share price post-earnings
Periodicals	PPL share buys at UBS flagged at Dealreporter on bank's link to activists » 09:39 08/11/22 08/11 09:39 08/11/22 09:39 PPL PPL Corp. $29.01 / +0.515 (+1.81%) UBS, which has a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PPL PPL Corp. $29.01 / +0.515 (+1.81%) 06/09/22 PPL Corp. increases common stock dividend to 22.5c from 20c per share 06/09/22 PPL Corp. management to provide update on strategic financial targets 05/25/22 PPL Corp. completes acquisition of Narragansett Electric from National Grid 05/23/22 PPL says Rhode Island court clears way for Narragansett Electric acquisition PPL PPL Corp. $29.01 / +0.515 (+1.81%) 07/14/22 Mizuho PPL Corp. price target lowered to $29 from $30 at Mizuho 07/07/22 Evercore ISI PPL Corp. upgraded to Outperform at Evercore ISI with re-rating expected 07/07/22 Evercore ISI PPL Corp. upgraded to Outperform from In Line at Evercore ISI 06/07/22 Wells Fargo PPL Corp. price target raised to $34 from $33 at Wells Fargo PPL PPL Corp. $29.01 / +0.515 (+1.81%) 08/03/22 PPL Corp. backs 2022 ongoing EPS view $1.30-$1.45, consensus $1.42 08/03/22 PPL Corp. reports Q2 ongoing EPS 30c, consensus 29c 05/05/22 PPL Corp. reports Q1 operating EPS 41c, consensus 39c 02/18/22 PPL Corp. reports Q4 adjusted EPS 22c, consensus 32c

Hot Stocks	Veru trading halted, volatility trading pause 09:39 08/11/22 08/11 09:39 08/11/22 09:39 VERU Veru $11.77 / +0.275 (+2.39%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VERU Veru $11.77 / +0.275 (+2.39%) 08/09/22 Veru announces presentation of phase 3 study of Sabizabulin 07/27/22 Veru says EMA's ETF initiates review of sabizabulin for COVID-19 patients 07/25/22 Veru announces UK's MHRA supports expedited review of MAA for sabizabulin 07/08/22 Veru down 9% after Culper releases follow-up short report VERU Veru $11.77 / +0.275 (+2.39%) 08/03/22 Oppenheimer Oppenheimer says analysis provides context on Veru COVID Phase 3 mortality rates 07/06/22 Jefferies Veru data likely portend FDA authorization in 30 days, says Jefferies 05/18/22 Brookline Veru price target raised to $31 from $29 at Brookline 05/13/22 Jefferies Veru price target raised to $55 from $33 at Jefferies VERU Veru $11.77 / +0.275 (+2.39%) 06:45 Today Veru reports Q3 EPS (28c), consensus (18c) 05/12/22 Veru reports Q2 EPS (18c), consensus (15c) VERU Veru $11.77 / +0.275 (+2.39%) 07/08/22 Culper Research says short Veru, sees ' little to no hope of' sabizabulin EUA 05/02/22 Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter' 04/11/22 STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm VERU Veru $11.77 / +0.275 (+2.39%) 07/08/22 What You Missed On Wall Street On Friday 07/08/22 What You Missed On Wall Street This Morning 07/06/22 Fly Intel: After-Hours Movers 07/06/22 What You Missed On Wall Street On Wednesday 08:00 Today Veru - VERU VERU Veru $11.77 / +0.275 (+2.39%) 07/07/22 Veru call volume above normal and directionally bullish 06/27/22 Veru call volume above normal and directionally bullish 06/07/22 Veru call volume above normal and directionally bullish 06/07/22 Unusually active option classes on open June 7th
Conference/Events	Bayer to hold a showcase » 09:37 08/11/22 08/11 09:37 08/11/22 09:37 BAYRY Bayer $13.35 / +0.094 (+0.71%) Crop Science Field… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BAYRY Bayer $13.35 / +0.094 (+0.71%) 08/05/22 FDA approves Bayer darolutamide tablets for prostate cancer 07/28/22 Ionis Pharmaceuticals announces 'positive' results from Phase 2b RE-THINC ESRD 07/05/22 Lyra Therapeutics appoints Nieman as Chief Medical Officer 06/28/22 Bayer's Kerendia recives new grade A recommendations from ADA BAYRY Bayer $13.35 / +0.094 (+0.71%) 07/20/22 Morgan Stanley Bayer price target raised to EUR 85 from EUR 83 at Morgan Stanley 06/13/22 Redburn FMC downgraded to Neutral on cost inflation at Redburn 05/19/22 UBS Bayer price target raised to EUR 96 from EUR 90 at UBS 05/11/22 Barclays Bayer price target raised to EUR 90 from EUR 85 at Barclays BAYRY Bayer $13.35 / +0.094 (+0.71%) 08/04/22 Bayer raises FY core EPS view to EUR7.30 vs. EUR7.00 previously 08/04/22 Bayer reports Q2 core EPS EUR1.93 vs. EUR1.61 last year 05/10/22 Bayer reports Q1 core EPS EUR 3.53 vs. EUR 2.59 last year 03/01/22 Bayer sees 2022 group sales of EUR 47B BAYRY Bayer $13.35 / +0.094 (+0.71%) 06/27/22 Supreme Court lets $87M award against Bayer for Roundup stand, Bloomberg reports 06/21/22 Supreme Court rejects Bayer bid to end Roundup suits, Bloomberg reports 05/11/22 Biden administration asks Supreme Court to reject Roundup appeal, Reuters says BAYRY Bayer $13.35 / +0.094 (+0.71%) 06/27/22 What You Missed On Wall Street On Monday 06/27/22 What You Missed On Wall Street This Morning 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 09/16/22 Biotech/Biopharma 09/10/22 ESMO Congress 2022 00:00 Today Bayer
Hot Stocks	Invitae trading halted, volatility trading pause 09:37 08/11/22 08/11 09:37 08/11/22 09:37 NVTA Invitae $8.67 / +6.39 (+280.26%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NVTA Invitae $8.67 / +6.39 (+280.26%) 08/10/22 Invitae rises 46.1% 08/08/22 Cathie Wood's ARK Investment bought 813K shares of Invitae today 07/18/22 Invitae announces strategic business realignment 07/18/22 Invitae says Kenneth Knight to succeed Sean George as CEO NVTA Invitae $8.67 / +6.39 (+280.26%) 08/10/22 JPMorgan Invitae cut to Underweight at JPMorgan with future growth yet to be proven 08/10/22 JPMorgan Invitae downgraded to Underweight from Neutral at JPMorgan 07/26/22 Cowen Invitae cut to Market Perform at Cowen on debt refinancing uncertainty 07/26/22 Cowen Invitae downgraded to Market Perform from Outperform at Cowen NVTA Invitae $8.67 / +6.39 (+280.26%) 08/09/22 Invitae backs FY22 revenue growth of low double digits, consensus $542.96M 08/09/22 Invitae reports Q2 adjusted EPS (68c), consensus (76c) 07/18/22 Invitae sees second half of FY22 revenue flat over first half of FY22 07/18/22 Invitae sees Q2 revenue $136M, consensus $142.74M NVTA Invitae $8.67 / +6.39 (+280.26%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 07/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 Fly Intel: After-Hours Movers 09/10/22 ESMO Congress 2022 NVTA Invitae $8.67 / +6.39 (+280.26%) 08:00 Today Invitae call buyer realizes 3500% same-day gains 05/03/22 Invitae options imply 14.1% move in share price post-earnings 02/24/22 Invitae options imply 14.1% move in share price post-earnings
Hot Stocks	Zhong Yang Financial Group Ltd trading halted, volatility trading pause 09:37 08/11/22 08/11 09:37 08/11/22 09:37 TOP Top Financial $12.58 / -2.61 (-17.18%) ShowHide Related Items >><< Company News Syndicate On The Fly TOP Top Financial $12.58 / -2.61 (-17.18%) 08/09/22 Zhong Yang Financial Group Ltd trading resumes 08/09/22 Zhong Yang Financial Group Ltd trading halted, volatility trading pause 08/08/22 Zhong Yang Financial Group Ltd trading resumes 08/08/22 Zhong Yang Financial Group Ltd trading halted, volatility trading pause 01 Jun TOP Top Financial $12.58 / -2.61 (-17.18%) 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO 06/04/22 Opening Day: Zhong Yang rises 240% in market debut
Hot Stocks	Red Robin trading resumes 09:36 08/11/22 08/11 09:36 08/11/22 09:36 RRGB Red Robin $10.65 / +0.85 (+8.67%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly RRGB Red Robin $10.65 / +0.85 (+8.67%) 09:31 Today Red Robin trading halted, volatility trading pause 08/10/22 Red Robin cuts FY22 adjusted EBITDA view to at least $65M from $80M-$90M 08/10/22 Red Robin reports Q2 SSS up 6.7% y/y and up 4.1% from 2019 07/14/22 Red Robin names G.J. Hart as CEO RRGB Red Robin $10.65 / +0.85 (+8.67%) 06:32 Today Benchmark Red Robin downgraded to Hold from Buy at Benchmark 06:18 Today Benchmark Red Robin downgraded to Hold from Buy at Benchmark 04/18/22 Raymond James Red Robin downgraded to Market Perform from Outperform at Raymond James 04/18/22 Raymond James Red Robin downgraded to Market Perform from Outperform at Raymond James RRGB Red Robin $10.65 / +0.85 (+8.67%) 08/10/22 Red Robin reports Q2 EPS (75c) vs. (22c) last year 05/26/22 Red Robin reports Q1 EPS (12c), consensus (73c) 03/10/22 Red Robin reports Q4 EPS ($1.36), consensus (53c) RRGB Red Robin $10.65 / +0.85 (+8.67%) 08/10/22 Fly Intel: After-Hours Movers 07/14/22 Fly Intel: After-Hours Movers 06/06/22 Fly Intel: Pre-market Movers 05/26/22 Fly Intel: After-Hours Movers

Events

Earnings calls, analyst events, roadshows and more

SLVM
Today at 10:00

Sylvamo - SLVM Conference Calls
EGY
Today at 10:00

Vaalco Energy - EGY Conference Calls
ISSC
Today at 10:00

Innovative Solutions - ISSC Conference Calls
SWKH
Today at 10:00

SWK Holdings - SWKH Conference Calls
AVAH
Today at 10:00

Aveanna - AVAH Conference Calls
FNV
Today at 10:00

Franco-Nevada - FNV Conference Calls
NEON
Today at 10:00

Neonode - NEON Conference Calls
QTRHF
Today at 10:00

Quarterhill - QTRHF Conference Calls
AVAL
Today at 10:00

Grupo Aval - AVAL Conference Calls
MGIC
Today at 10:00

Magic Software - MGIC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares
Thurs	TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo $42.65-43.30 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams $41.42 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $11.11
Fri	No deals

View All Syndicate Announcements »

ITT remains a top idea following analyst day, says Baird

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access